A Study to Assess a PI3Kδ Inhibitor (IOA-244) in Patients With Metastatic Cancers
iOnctura
iOnctura
Tesaro, Inc.
Toray Industries, Inc
Eli Lilly and Company
Shanghai Junshi Bioscience Co., Ltd.
Thomas Jefferson University
Eli Lilly and Company
Case Comprehensive Cancer Center
M.D. Anderson Cancer Center
City of Hope Medical Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Mayo Clinic